Posts

Showing posts with the label fever

Dengue Vaccines Market Driving Growth Factors help to improve Business Scope in Near Future

Image
Dengue fever, often known as breakbone fever, is a viral virus transmitted by mosquitos that causes a severe flu-like disease. Severe dengue fever is a potentially fatal consequence of the disease. Dengue vaccine is a human vaccination that prevents dengue disease. Dengue vaccination is only indicated for people who have experienced dengue fever before. It is administered in three injections over the course of a year. Dengue Vaccines The development of a dengue vaccine has reached a critical point, with a slew of pharmaceutical behemoths scheduled to report the results of large clinical trials launched over the last decade or half-decade. The present Denvaxia® vaccine's exclusivity is expected to be broken by the availability of other competitors in the future. The global Dengue Vaccine Market is estimated to account for US$ 1,262.0 Mn in terms of value by the end of 2027. More clinical trials and research studies dedicated to identifying novel vaccine formulations are being f

Malaria Vaccines Market Future Scope Shows Huge growth over the forecast period

Image
  Malaria Vaccine According to World Health Organization statistics, about half of the world's population is at risk of malaria (WHO). As a result, numerous healthcare organisations have been more interested in solving this serious problem. The Melinda Gates Foundation and PATH, two global non-profit organisations, are trying to develop malaria prevention techniques and save the lives of many people in malaria-affected areas. Because Africa accounts for 90% of malaria occurrences, the introduction of GlaxoSmithKline plc's first malaria vaccine is aimed primarily at this continent. Mosquirix was approved by the European Union in 2015 and is currently being tested in Africa as part of a pilot project. The global Malaria Vaccines Market is expected to be valued at US$ 50.6 million in 2024 and is expected to witness a CAGR of 150.0% during the forecast period (2024 – 2027). This mosquito-borne infection causes severe illness in both children and adults. The effects of high fever

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides